Global Remicade Biosimilar Market Growth 2025-2031
The global Remicade Biosimilar market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A Remicade biosimilar is a biologic medication that is highly similar to Remicade, a brand-name biologic used to treat autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis.
The market for Remicade biosimilars is driven by the increasing demand for cost-effective biologic therapies and the expiration of Remicade's patent, leading to the entry of biosimilar competitors. The market's growth is also influenced by regulatory support for biosimilars and the ongoing development of new biologic therapies.
LP Information, Inc. (LPI) ' newest research report, the ?Remicade Biosimilar Industry Forecast? looks at past sales and reviews total world Remicade Biosimilar sales in 2024, providing a comprehensive analysis by region and market sector of projected Remicade Biosimilar sales for 2025 through 2031. With Remicade Biosimilar sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Remicade Biosimilar industry.
This Insight Report provides a comprehensive analysis of the global Remicade Biosimilar landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Remicade Biosimilar portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Remicade Biosimilar market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Remicade Biosimilar and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Remicade Biosimilar.
This report presents a comprehensive overview, market shares, and growth opportunities of Remicade Biosimilar market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Remicade Biosimilar market?
What factors are driving Remicade Biosimilar market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Remicade Biosimilar market opportunities vary by end market size?
How does Remicade Biosimilar break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
A Remicade biosimilar is a biologic medication that is highly similar to Remicade, a brand-name biologic used to treat autoimmune diseases such as rheumatoid arthritis, Crohn's disease, and psoriasis.
The market for Remicade biosimilars is driven by the increasing demand for cost-effective biologic therapies and the expiration of Remicade's patent, leading to the entry of biosimilar competitors. The market's growth is also influenced by regulatory support for biosimilars and the ongoing development of new biologic therapies.
LP Information, Inc. (LPI) ' newest research report, the ?Remicade Biosimilar Industry Forecast? looks at past sales and reviews total world Remicade Biosimilar sales in 2024, providing a comprehensive analysis by region and market sector of projected Remicade Biosimilar sales for 2025 through 2031. With Remicade Biosimilar sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Remicade Biosimilar industry.
This Insight Report provides a comprehensive analysis of the global Remicade Biosimilar landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Remicade Biosimilar portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms? unique position in an accelerating global Remicade Biosimilar market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Remicade Biosimilar and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Remicade Biosimilar.
This report presents a comprehensive overview, market shares, and growth opportunities of Remicade Biosimilar market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 100mg/10ml
- 500mg/50ml
- Blood Disorders
- Oncology Diseases
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Synthon Pharmaceuticals
- LG Life Sciences
- Novartis (Sandoz)
- Celltrion
- Biocon
- Hospira
- Merck Serono (Merck Group)
- Biogen idec Inc.
- Genentech (Roche Group)
- Fosun Pharmaceutical
- Livzon Pharmaceutical
- Anke Biotechnology
- Hualan Biological Engineering
- Walvax Biotechnology
- Hisun Pharmaceutical
What is the 10-year outlook for the global Remicade Biosimilar market?
What factors are driving Remicade Biosimilar market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Remicade Biosimilar market opportunities vary by end market size?
How does Remicade Biosimilar break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Remicade Biosimilar Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Remicade Biosimilar by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Remicade Biosimilar by Country/Region, 2020, 2024 & 2031
2.2 Remicade Biosimilar Segment by Type
2.2.1 100mg/10ml
2.2.2 500mg/50ml
2.3 Remicade Biosimilar Sales by Type
2.3.1 Global Remicade Biosimilar Sales Market Share by Type (2020-2025)
2.3.2 Global Remicade Biosimilar Revenue and Market Share by Type (2020-2025)
2.3.3 Global Remicade Biosimilar Sale Price by Type (2020-2025)
2.4 Remicade Biosimilar Segment by Application
2.4.1 Blood Disorders
2.4.2 Oncology Diseases
2.5 Remicade Biosimilar Sales by Application
2.5.1 Global Remicade Biosimilar Sale Market Share by Application (2020-2025)
2.5.2 Global Remicade Biosimilar Revenue and Market Share by Application (2020-2025)
2.5.3 Global Remicade Biosimilar Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Remicade Biosimilar Breakdown Data by Company
3.1.1 Global Remicade Biosimilar Annual Sales by Company (2020-2025)
3.1.2 Global Remicade Biosimilar Sales Market Share by Company (2020-2025)
3.2 Global Remicade Biosimilar Annual Revenue by Company (2020-2025)
3.2.1 Global Remicade Biosimilar Revenue by Company (2020-2025)
3.2.2 Global Remicade Biosimilar Revenue Market Share by Company (2020-2025)
3.3 Global Remicade Biosimilar Sale Price by Company
3.4 Key Manufacturers Remicade Biosimilar Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Remicade Biosimilar Product Location Distribution
3.4.2 Players Remicade Biosimilar Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR REMICADE BIOSIMILAR BY GEOGRAPHIC REGION
4.1 World Historic Remicade Biosimilar Market Size by Geographic Region (2020-2025)
4.1.1 Global Remicade Biosimilar Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Remicade Biosimilar Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Remicade Biosimilar Market Size by Country/Region (2020-2025)
4.2.1 Global Remicade Biosimilar Annual Sales by Country/Region (2020-2025)
4.2.2 Global Remicade Biosimilar Annual Revenue by Country/Region (2020-2025)
4.3 Americas Remicade Biosimilar Sales Growth
4.4 APAC Remicade Biosimilar Sales Growth
4.5 Europe Remicade Biosimilar Sales Growth
4.6 Middle East & Africa Remicade Biosimilar Sales Growth
5 AMERICAS
5.1 Americas Remicade Biosimilar Sales by Country
5.1.1 Americas Remicade Biosimilar Sales by Country (2020-2025)
5.1.2 Americas Remicade Biosimilar Revenue by Country (2020-2025)
5.2 Americas Remicade Biosimilar Sales by Type (2020-2025)
5.3 Americas Remicade Biosimilar Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Remicade Biosimilar Sales by Region
6.1.1 APAC Remicade Biosimilar Sales by Region (2020-2025)
6.1.2 APAC Remicade Biosimilar Revenue by Region (2020-2025)
6.2 APAC Remicade Biosimilar Sales by Type (2020-2025)
6.3 APAC Remicade Biosimilar Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Remicade Biosimilar by Country
7.1.1 Europe Remicade Biosimilar Sales by Country (2020-2025)
7.1.2 Europe Remicade Biosimilar Revenue by Country (2020-2025)
7.2 Europe Remicade Biosimilar Sales by Type (2020-2025)
7.3 Europe Remicade Biosimilar Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Remicade Biosimilar by Country
8.1.1 Middle East & Africa Remicade Biosimilar Sales by Country (2020-2025)
8.1.2 Middle East & Africa Remicade Biosimilar Revenue by Country (2020-2025)
8.2 Middle East & Africa Remicade Biosimilar Sales by Type (2020-2025)
8.3 Middle East & Africa Remicade Biosimilar Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Remicade Biosimilar
10.3 Manufacturing Process Analysis of Remicade Biosimilar
10.4 Industry Chain Structure of Remicade Biosimilar
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Remicade Biosimilar Distributors
11.3 Remicade Biosimilar Customer
12 WORLD FORECAST REVIEW FOR REMICADE BIOSIMILAR BY GEOGRAPHIC REGION
12.1 Global Remicade Biosimilar Market Size Forecast by Region
12.1.1 Global Remicade Biosimilar Forecast by Region (2026-2031)
12.1.2 Global Remicade Biosimilar Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Remicade Biosimilar Forecast by Type (2026-2031)
12.7 Global Remicade Biosimilar Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Synthon Pharmaceuticals
13.1.1 Synthon Pharmaceuticals Company Information
13.1.2 Synthon Pharmaceuticals Remicade Biosimilar Product Portfolios and Specifications
13.1.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Synthon Pharmaceuticals Main Business Overview
13.1.5 Synthon Pharmaceuticals Latest Developments
13.2 LG Life Sciences
13.2.1 LG Life Sciences Company Information
13.2.2 LG Life Sciences Remicade Biosimilar Product Portfolios and Specifications
13.2.3 LG Life Sciences Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 LG Life Sciences Main Business Overview
13.2.5 LG Life Sciences Latest Developments
13.3 Novartis (Sandoz)
13.3.1 Novartis (Sandoz) Company Information
13.3.2 Novartis (Sandoz) Remicade Biosimilar Product Portfolios and Specifications
13.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novartis (Sandoz) Main Business Overview
13.3.5 Novartis (Sandoz) Latest Developments
13.4 Celltrion
13.4.1 Celltrion Company Information
13.4.2 Celltrion Remicade Biosimilar Product Portfolios and Specifications
13.4.3 Celltrion Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Celltrion Main Business Overview
13.4.5 Celltrion Latest Developments
13.5 Biocon
13.5.1 Biocon Company Information
13.5.2 Biocon Remicade Biosimilar Product Portfolios and Specifications
13.5.3 Biocon Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Biocon Main Business Overview
13.5.5 Biocon Latest Developments
13.6 Hospira
13.6.1 Hospira Company Information
13.6.2 Hospira Remicade Biosimilar Product Portfolios and Specifications
13.6.3 Hospira Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hospira Main Business Overview
13.6.5 Hospira Latest Developments
13.7 Merck Serono (Merck Group)
13.7.1 Merck Serono (Merck Group) Company Information
13.7.2 Merck Serono (Merck Group) Remicade Biosimilar Product Portfolios and Specifications
13.7.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Merck Serono (Merck Group) Main Business Overview
13.7.5 Merck Serono (Merck Group) Latest Developments
13.8 Biogen idec Inc.
13.8.1 Biogen idec Inc. Company Information
13.8.2 Biogen idec Inc. Remicade Biosimilar Product Portfolios and Specifications
13.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Biogen idec Inc. Main Business Overview
13.8.5 Biogen idec Inc. Latest Developments
13.9 Genentech (Roche Group)
13.9.1 Genentech (Roche Group) Company Information
13.9.2 Genentech (Roche Group) Remicade Biosimilar Product Portfolios and Specifications
13.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Genentech (Roche Group) Main Business Overview
13.9.5 Genentech (Roche Group) Latest Developments
13.10 Fosun Pharmaceutical
13.10.1 Fosun Pharmaceutical Company Information
13.10.2 Fosun Pharmaceutical Remicade Biosimilar Product Portfolios and Specifications
13.10.3 Fosun Pharmaceutical Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Fosun Pharmaceutical Main Business Overview
13.10.5 Fosun Pharmaceutical Latest Developments
13.11 Livzon Pharmaceutical
13.11.1 Livzon Pharmaceutical Company Information
13.11.2 Livzon Pharmaceutical Remicade Biosimilar Product Portfolios and Specifications
13.11.3 Livzon Pharmaceutical Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Livzon Pharmaceutical Main Business Overview
13.11.5 Livzon Pharmaceutical Latest Developments
13.12 Anke Biotechnology
13.12.1 Anke Biotechnology Company Information
13.12.2 Anke Biotechnology Remicade Biosimilar Product Portfolios and Specifications
13.12.3 Anke Biotechnology Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Anke Biotechnology Main Business Overview
13.12.5 Anke Biotechnology Latest Developments
13.13 Hualan Biological Engineering
13.13.1 Hualan Biological Engineering Company Information
13.13.2 Hualan Biological Engineering Remicade Biosimilar Product Portfolios and Specifications
13.13.3 Hualan Biological Engineering Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hualan Biological Engineering Main Business Overview
13.13.5 Hualan Biological Engineering Latest Developments
13.14 Walvax Biotechnology
13.14.1 Walvax Biotechnology Company Information
13.14.2 Walvax Biotechnology Remicade Biosimilar Product Portfolios and Specifications
13.14.3 Walvax Biotechnology Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Walvax Biotechnology Main Business Overview
13.14.5 Walvax Biotechnology Latest Developments
13.15 Hisun Pharmaceutical
13.15.1 Hisun Pharmaceutical Company Information
13.15.2 Hisun Pharmaceutical Remicade Biosimilar Product Portfolios and Specifications
13.15.3 Hisun Pharmaceutical Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Hisun Pharmaceutical Main Business Overview
13.15.5 Hisun Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Remicade Biosimilar Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Remicade Biosimilar by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Remicade Biosimilar by Country/Region, 2020, 2024 & 2031
2.2 Remicade Biosimilar Segment by Type
2.2.1 100mg/10ml
2.2.2 500mg/50ml
2.3 Remicade Biosimilar Sales by Type
2.3.1 Global Remicade Biosimilar Sales Market Share by Type (2020-2025)
2.3.2 Global Remicade Biosimilar Revenue and Market Share by Type (2020-2025)
2.3.3 Global Remicade Biosimilar Sale Price by Type (2020-2025)
2.4 Remicade Biosimilar Segment by Application
2.4.1 Blood Disorders
2.4.2 Oncology Diseases
2.5 Remicade Biosimilar Sales by Application
2.5.1 Global Remicade Biosimilar Sale Market Share by Application (2020-2025)
2.5.2 Global Remicade Biosimilar Revenue and Market Share by Application (2020-2025)
2.5.3 Global Remicade Biosimilar Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Remicade Biosimilar Breakdown Data by Company
3.1.1 Global Remicade Biosimilar Annual Sales by Company (2020-2025)
3.1.2 Global Remicade Biosimilar Sales Market Share by Company (2020-2025)
3.2 Global Remicade Biosimilar Annual Revenue by Company (2020-2025)
3.2.1 Global Remicade Biosimilar Revenue by Company (2020-2025)
3.2.2 Global Remicade Biosimilar Revenue Market Share by Company (2020-2025)
3.3 Global Remicade Biosimilar Sale Price by Company
3.4 Key Manufacturers Remicade Biosimilar Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Remicade Biosimilar Product Location Distribution
3.4.2 Players Remicade Biosimilar Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR REMICADE BIOSIMILAR BY GEOGRAPHIC REGION
4.1 World Historic Remicade Biosimilar Market Size by Geographic Region (2020-2025)
4.1.1 Global Remicade Biosimilar Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Remicade Biosimilar Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Remicade Biosimilar Market Size by Country/Region (2020-2025)
4.2.1 Global Remicade Biosimilar Annual Sales by Country/Region (2020-2025)
4.2.2 Global Remicade Biosimilar Annual Revenue by Country/Region (2020-2025)
4.3 Americas Remicade Biosimilar Sales Growth
4.4 APAC Remicade Biosimilar Sales Growth
4.5 Europe Remicade Biosimilar Sales Growth
4.6 Middle East & Africa Remicade Biosimilar Sales Growth
5 AMERICAS
5.1 Americas Remicade Biosimilar Sales by Country
5.1.1 Americas Remicade Biosimilar Sales by Country (2020-2025)
5.1.2 Americas Remicade Biosimilar Revenue by Country (2020-2025)
5.2 Americas Remicade Biosimilar Sales by Type (2020-2025)
5.3 Americas Remicade Biosimilar Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Remicade Biosimilar Sales by Region
6.1.1 APAC Remicade Biosimilar Sales by Region (2020-2025)
6.1.2 APAC Remicade Biosimilar Revenue by Region (2020-2025)
6.2 APAC Remicade Biosimilar Sales by Type (2020-2025)
6.3 APAC Remicade Biosimilar Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Remicade Biosimilar by Country
7.1.1 Europe Remicade Biosimilar Sales by Country (2020-2025)
7.1.2 Europe Remicade Biosimilar Revenue by Country (2020-2025)
7.2 Europe Remicade Biosimilar Sales by Type (2020-2025)
7.3 Europe Remicade Biosimilar Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Remicade Biosimilar by Country
8.1.1 Middle East & Africa Remicade Biosimilar Sales by Country (2020-2025)
8.1.2 Middle East & Africa Remicade Biosimilar Revenue by Country (2020-2025)
8.2 Middle East & Africa Remicade Biosimilar Sales by Type (2020-2025)
8.3 Middle East & Africa Remicade Biosimilar Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Remicade Biosimilar
10.3 Manufacturing Process Analysis of Remicade Biosimilar
10.4 Industry Chain Structure of Remicade Biosimilar
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Remicade Biosimilar Distributors
11.3 Remicade Biosimilar Customer
12 WORLD FORECAST REVIEW FOR REMICADE BIOSIMILAR BY GEOGRAPHIC REGION
12.1 Global Remicade Biosimilar Market Size Forecast by Region
12.1.1 Global Remicade Biosimilar Forecast by Region (2026-2031)
12.1.2 Global Remicade Biosimilar Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Remicade Biosimilar Forecast by Type (2026-2031)
12.7 Global Remicade Biosimilar Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Synthon Pharmaceuticals
13.1.1 Synthon Pharmaceuticals Company Information
13.1.2 Synthon Pharmaceuticals Remicade Biosimilar Product Portfolios and Specifications
13.1.3 Synthon Pharmaceuticals Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Synthon Pharmaceuticals Main Business Overview
13.1.5 Synthon Pharmaceuticals Latest Developments
13.2 LG Life Sciences
13.2.1 LG Life Sciences Company Information
13.2.2 LG Life Sciences Remicade Biosimilar Product Portfolios and Specifications
13.2.3 LG Life Sciences Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 LG Life Sciences Main Business Overview
13.2.5 LG Life Sciences Latest Developments
13.3 Novartis (Sandoz)
13.3.1 Novartis (Sandoz) Company Information
13.3.2 Novartis (Sandoz) Remicade Biosimilar Product Portfolios and Specifications
13.3.3 Novartis (Sandoz) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Novartis (Sandoz) Main Business Overview
13.3.5 Novartis (Sandoz) Latest Developments
13.4 Celltrion
13.4.1 Celltrion Company Information
13.4.2 Celltrion Remicade Biosimilar Product Portfolios and Specifications
13.4.3 Celltrion Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Celltrion Main Business Overview
13.4.5 Celltrion Latest Developments
13.5 Biocon
13.5.1 Biocon Company Information
13.5.2 Biocon Remicade Biosimilar Product Portfolios and Specifications
13.5.3 Biocon Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Biocon Main Business Overview
13.5.5 Biocon Latest Developments
13.6 Hospira
13.6.1 Hospira Company Information
13.6.2 Hospira Remicade Biosimilar Product Portfolios and Specifications
13.6.3 Hospira Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Hospira Main Business Overview
13.6.5 Hospira Latest Developments
13.7 Merck Serono (Merck Group)
13.7.1 Merck Serono (Merck Group) Company Information
13.7.2 Merck Serono (Merck Group) Remicade Biosimilar Product Portfolios and Specifications
13.7.3 Merck Serono (Merck Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Merck Serono (Merck Group) Main Business Overview
13.7.5 Merck Serono (Merck Group) Latest Developments
13.8 Biogen idec Inc.
13.8.1 Biogen idec Inc. Company Information
13.8.2 Biogen idec Inc. Remicade Biosimilar Product Portfolios and Specifications
13.8.3 Biogen idec Inc. Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Biogen idec Inc. Main Business Overview
13.8.5 Biogen idec Inc. Latest Developments
13.9 Genentech (Roche Group)
13.9.1 Genentech (Roche Group) Company Information
13.9.2 Genentech (Roche Group) Remicade Biosimilar Product Portfolios and Specifications
13.9.3 Genentech (Roche Group) Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Genentech (Roche Group) Main Business Overview
13.9.5 Genentech (Roche Group) Latest Developments
13.10 Fosun Pharmaceutical
13.10.1 Fosun Pharmaceutical Company Information
13.10.2 Fosun Pharmaceutical Remicade Biosimilar Product Portfolios and Specifications
13.10.3 Fosun Pharmaceutical Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Fosun Pharmaceutical Main Business Overview
13.10.5 Fosun Pharmaceutical Latest Developments
13.11 Livzon Pharmaceutical
13.11.1 Livzon Pharmaceutical Company Information
13.11.2 Livzon Pharmaceutical Remicade Biosimilar Product Portfolios and Specifications
13.11.3 Livzon Pharmaceutical Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Livzon Pharmaceutical Main Business Overview
13.11.5 Livzon Pharmaceutical Latest Developments
13.12 Anke Biotechnology
13.12.1 Anke Biotechnology Company Information
13.12.2 Anke Biotechnology Remicade Biosimilar Product Portfolios and Specifications
13.12.3 Anke Biotechnology Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Anke Biotechnology Main Business Overview
13.12.5 Anke Biotechnology Latest Developments
13.13 Hualan Biological Engineering
13.13.1 Hualan Biological Engineering Company Information
13.13.2 Hualan Biological Engineering Remicade Biosimilar Product Portfolios and Specifications
13.13.3 Hualan Biological Engineering Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Hualan Biological Engineering Main Business Overview
13.13.5 Hualan Biological Engineering Latest Developments
13.14 Walvax Biotechnology
13.14.1 Walvax Biotechnology Company Information
13.14.2 Walvax Biotechnology Remicade Biosimilar Product Portfolios and Specifications
13.14.3 Walvax Biotechnology Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Walvax Biotechnology Main Business Overview
13.14.5 Walvax Biotechnology Latest Developments
13.15 Hisun Pharmaceutical
13.15.1 Hisun Pharmaceutical Company Information
13.15.2 Hisun Pharmaceutical Remicade Biosimilar Product Portfolios and Specifications
13.15.3 Hisun Pharmaceutical Remicade Biosimilar Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Hisun Pharmaceutical Main Business Overview
13.15.5 Hisun Pharmaceutical Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Remicade Biosimilar Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Remicade Biosimilar Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 100mg/10ml
Table 4. Major Players of 500mg/50ml
Table 5. Global Remicade Biosimilar Sales by Type (2020-2025) & (L)
Table 6. Global Remicade Biosimilar Sales Market Share by Type (2020-2025)
Table 7. Global Remicade Biosimilar Revenue by Type (2020-2025) & ($ million)
Table 8. Global Remicade Biosimilar Revenue Market Share by Type (2020-2025)
Table 9. Global Remicade Biosimilar Sale Price by Type (2020-2025) & (US$/Ml)
Table 10. Global Remicade Biosimilar Sale by Application (2020-2025) & (L)
Table 11. Global Remicade Biosimilar Sale Market Share by Application (2020-2025)
Table 12. Global Remicade Biosimilar Revenue by Application (2020-2025) & ($ million)
Table 13. Global Remicade Biosimilar Revenue Market Share by Application (2020-2025)
Table 14. Global Remicade Biosimilar Sale Price by Application (2020-2025) & (US$/Ml)
Table 15. Global Remicade Biosimilar Sales by Company (2020-2025) & (L)
Table 16. Global Remicade Biosimilar Sales Market Share by Company (2020-2025)
Table 17. Global Remicade Biosimilar Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Remicade Biosimilar Revenue Market Share by Company (2020-2025)
Table 19. Global Remicade Biosimilar Sale Price by Company (2020-2025) & (US$/Ml)
Table 20. Key Manufacturers Remicade Biosimilar Producing Area Distribution and Sales Area
Table 21. Players Remicade Biosimilar Products Offered
Table 22. Remicade Biosimilar Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Remicade Biosimilar Sales by Geographic Region (2020-2025) & (L)
Table 26. Global Remicade Biosimilar Sales Market Share Geographic Region (2020-2025)
Table 27. Global Remicade Biosimilar Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Remicade Biosimilar Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Remicade Biosimilar Sales by Country/Region (2020-2025) & (L)
Table 30. Global Remicade Biosimilar Sales Market Share by Country/Region (2020-2025)
Table 31. Global Remicade Biosimilar Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Remicade Biosimilar Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Remicade Biosimilar Sales by Country (2020-2025) & (L)
Table 34. Americas Remicade Biosimilar Sales Market Share by Country (2020-2025)
Table 35. Americas Remicade Biosimilar Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Remicade Biosimilar Sales by Type (2020-2025) & (L)
Table 37. Americas Remicade Biosimilar Sales by Application (2020-2025) & (L)
Table 38. APAC Remicade Biosimilar Sales by Region (2020-2025) & (L)
Table 39. APAC Remicade Biosimilar Sales Market Share by Region (2020-2025)
Table 40. APAC Remicade Biosimilar Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Remicade Biosimilar Sales by Type (2020-2025) & (L)
Table 42. APAC Remicade Biosimilar Sales by Application (2020-2025) & (L)
Table 43. Europe Remicade Biosimilar Sales by Country (2020-2025) & (L)
Table 44. Europe Remicade Biosimilar Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Remicade Biosimilar Sales by Type (2020-2025) & (L)
Table 46. Europe Remicade Biosimilar Sales by Application (2020-2025) & (L)
Table 47. Middle East & Africa Remicade Biosimilar Sales by Country (2020-2025) & (L)
Table 48. Middle East & Africa Remicade Biosimilar Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Remicade Biosimilar Sales by Type (2020-2025) & (L)
Table 50. Middle East & Africa Remicade Biosimilar Sales by Application (2020-2025) & (L)
Table 51. Key Market Drivers & Growth Opportunities of Remicade Biosimilar
Table 52. Key Market Challenges & Risks of Remicade Biosimilar
Table 53. Key Industry Trends of Remicade Biosimilar
Table 54. Remicade Biosimilar Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Remicade Biosimilar Distributors List
Table 57. Remicade Biosimilar Customer List
Table 58. Global Remicade Biosimilar Sales Forecast by Region (2026-2031) & (L)
Table 59. Global Remicade Biosimilar Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Remicade Biosimilar Sales Forecast by Country (2026-2031) & (L)
Table 61. Americas Remicade Biosimilar Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Remicade Biosimilar Sales Forecast by Region (2026-2031) & (L)
Table 63. APAC Remicade Biosimilar Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Remicade Biosimilar Sales Forecast by Country (2026-2031) & (L)
Table 65. Europe Remicade Biosimilar Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Remicade Biosimilar Sales Forecast by Country (2026-2031) & (L)
Table 67. Middle East & Africa Remicade Biosimilar Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Remicade Biosimilar Sales Forecast by Type (2026-2031) & (L)
Table 69. Global Remicade Biosimilar Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Remicade Biosimilar Sales Forecast by Application (2026-2031) & (L)
Table 71. Global Remicade Biosimilar Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Synthon Pharmaceuticals Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 73. Synthon Pharmaceuticals Remicade Biosimilar Product Portfolios and Specifications
Table 74. Synthon Pharmaceuticals Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 75. Synthon Pharmaceuticals Main Business
Table 76. Synthon Pharmaceuticals Latest Developments
Table 77. LG Life Sciences Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 78. LG Life Sciences Remicade Biosimilar Product Portfolios and Specifications
Table 79. LG Life Sciences Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 80. LG Life Sciences Main Business
Table 81. LG Life Sciences Latest Developments
Table 82. Novartis (Sandoz) Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 83. Novartis (Sandoz) Remicade Biosimilar Product Portfolios and Specifications
Table 84. Novartis (Sandoz) Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 85. Novartis (Sandoz) Main Business
Table 86. Novartis (Sandoz) Latest Developments
Table 87. Celltrion Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 88. Celltrion Remicade Biosimilar Product Portfolios and Specifications
Table 89. Celltrion Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 90. Celltrion Main Business
Table 91. Celltrion Latest Developments
Table 92. Biocon Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 93. Biocon Remicade Biosimilar Product Portfolios and Specifications
Table 94. Biocon Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 95. Biocon Main Business
Table 96. Biocon Latest Developments
Table 97. Hospira Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 98. Hospira Remicade Biosimilar Product Portfolios and Specifications
Table 99. Hospira Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 100. Hospira Main Business
Table 101. Hospira Latest Developments
Table 102. Merck Serono (Merck Group) Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck Serono (Merck Group) Remicade Biosimilar Product Portfolios and Specifications
Table 104. Merck Serono (Merck Group) Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 105. Merck Serono (Merck Group) Main Business
Table 106. Merck Serono (Merck Group) Latest Developments
Table 107. Biogen idec Inc. Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 108. Biogen idec Inc. Remicade Biosimilar Product Portfolios and Specifications
Table 109. Biogen idec Inc. Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 110. Biogen idec Inc. Main Business
Table 111. Biogen idec Inc. Latest Developments
Table 112. Genentech (Roche Group) Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 113. Genentech (Roche Group) Remicade Biosimilar Product Portfolios and Specifications
Table 114. Genentech (Roche Group) Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 115. Genentech (Roche Group) Main Business
Table 116. Genentech (Roche Group) Latest Developments
Table 117. Fosun Pharmaceutical Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 118. Fosun Pharmaceutical Remicade Biosimilar Product Portfolios and Specifications
Table 119. Fosun Pharmaceutical Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 120. Fosun Pharmaceutical Main Business
Table 121. Fosun Pharmaceutical Latest Developments
Table 122. Livzon Pharmaceutical Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 123. Livzon Pharmaceutical Remicade Biosimilar Product Portfolios and Specifications
Table 124. Livzon Pharmaceutical Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 125. Livzon Pharmaceutical Main Business
Table 126. Livzon Pharmaceutical Latest Developments
Table 127. Anke Biotechnology Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 128. Anke Biotechnology Remicade Biosimilar Product Portfolios and Specifications
Table 129. Anke Biotechnology Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 130. Anke Biotechnology Main Business
Table 131. Anke Biotechnology Latest Developments
Table 132. Hualan Biological Engineering Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 133. Hualan Biological Engineering Remicade Biosimilar Product Portfolios and Specifications
Table 134. Hualan Biological Engineering Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 135. Hualan Biological Engineering Main Business
Table 136. Hualan Biological Engineering Latest Developments
Table 137. Walvax Biotechnology Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 138. Walvax Biotechnology Remicade Biosimilar Product Portfolios and Specifications
Table 139. Walvax Biotechnology Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 140. Walvax Biotechnology Main Business
Table 141. Walvax Biotechnology Latest Developments
Table 142. Hisun Pharmaceutical Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 143. Hisun Pharmaceutical Remicade Biosimilar Product Portfolios and Specifications
Table 144. Hisun Pharmaceutical Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 145. Hisun Pharmaceutical Main Business
Table 146. Hisun Pharmaceutical Latest Developments
Table 1. Remicade Biosimilar Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Remicade Biosimilar Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 100mg/10ml
Table 4. Major Players of 500mg/50ml
Table 5. Global Remicade Biosimilar Sales by Type (2020-2025) & (L)
Table 6. Global Remicade Biosimilar Sales Market Share by Type (2020-2025)
Table 7. Global Remicade Biosimilar Revenue by Type (2020-2025) & ($ million)
Table 8. Global Remicade Biosimilar Revenue Market Share by Type (2020-2025)
Table 9. Global Remicade Biosimilar Sale Price by Type (2020-2025) & (US$/Ml)
Table 10. Global Remicade Biosimilar Sale by Application (2020-2025) & (L)
Table 11. Global Remicade Biosimilar Sale Market Share by Application (2020-2025)
Table 12. Global Remicade Biosimilar Revenue by Application (2020-2025) & ($ million)
Table 13. Global Remicade Biosimilar Revenue Market Share by Application (2020-2025)
Table 14. Global Remicade Biosimilar Sale Price by Application (2020-2025) & (US$/Ml)
Table 15. Global Remicade Biosimilar Sales by Company (2020-2025) & (L)
Table 16. Global Remicade Biosimilar Sales Market Share by Company (2020-2025)
Table 17. Global Remicade Biosimilar Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Remicade Biosimilar Revenue Market Share by Company (2020-2025)
Table 19. Global Remicade Biosimilar Sale Price by Company (2020-2025) & (US$/Ml)
Table 20. Key Manufacturers Remicade Biosimilar Producing Area Distribution and Sales Area
Table 21. Players Remicade Biosimilar Products Offered
Table 22. Remicade Biosimilar Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Remicade Biosimilar Sales by Geographic Region (2020-2025) & (L)
Table 26. Global Remicade Biosimilar Sales Market Share Geographic Region (2020-2025)
Table 27. Global Remicade Biosimilar Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Remicade Biosimilar Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Remicade Biosimilar Sales by Country/Region (2020-2025) & (L)
Table 30. Global Remicade Biosimilar Sales Market Share by Country/Region (2020-2025)
Table 31. Global Remicade Biosimilar Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Remicade Biosimilar Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Remicade Biosimilar Sales by Country (2020-2025) & (L)
Table 34. Americas Remicade Biosimilar Sales Market Share by Country (2020-2025)
Table 35. Americas Remicade Biosimilar Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Remicade Biosimilar Sales by Type (2020-2025) & (L)
Table 37. Americas Remicade Biosimilar Sales by Application (2020-2025) & (L)
Table 38. APAC Remicade Biosimilar Sales by Region (2020-2025) & (L)
Table 39. APAC Remicade Biosimilar Sales Market Share by Region (2020-2025)
Table 40. APAC Remicade Biosimilar Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Remicade Biosimilar Sales by Type (2020-2025) & (L)
Table 42. APAC Remicade Biosimilar Sales by Application (2020-2025) & (L)
Table 43. Europe Remicade Biosimilar Sales by Country (2020-2025) & (L)
Table 44. Europe Remicade Biosimilar Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Remicade Biosimilar Sales by Type (2020-2025) & (L)
Table 46. Europe Remicade Biosimilar Sales by Application (2020-2025) & (L)
Table 47. Middle East & Africa Remicade Biosimilar Sales by Country (2020-2025) & (L)
Table 48. Middle East & Africa Remicade Biosimilar Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Remicade Biosimilar Sales by Type (2020-2025) & (L)
Table 50. Middle East & Africa Remicade Biosimilar Sales by Application (2020-2025) & (L)
Table 51. Key Market Drivers & Growth Opportunities of Remicade Biosimilar
Table 52. Key Market Challenges & Risks of Remicade Biosimilar
Table 53. Key Industry Trends of Remicade Biosimilar
Table 54. Remicade Biosimilar Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Remicade Biosimilar Distributors List
Table 57. Remicade Biosimilar Customer List
Table 58. Global Remicade Biosimilar Sales Forecast by Region (2026-2031) & (L)
Table 59. Global Remicade Biosimilar Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Remicade Biosimilar Sales Forecast by Country (2026-2031) & (L)
Table 61. Americas Remicade Biosimilar Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Remicade Biosimilar Sales Forecast by Region (2026-2031) & (L)
Table 63. APAC Remicade Biosimilar Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Remicade Biosimilar Sales Forecast by Country (2026-2031) & (L)
Table 65. Europe Remicade Biosimilar Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Remicade Biosimilar Sales Forecast by Country (2026-2031) & (L)
Table 67. Middle East & Africa Remicade Biosimilar Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Remicade Biosimilar Sales Forecast by Type (2026-2031) & (L)
Table 69. Global Remicade Biosimilar Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Remicade Biosimilar Sales Forecast by Application (2026-2031) & (L)
Table 71. Global Remicade Biosimilar Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Synthon Pharmaceuticals Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 73. Synthon Pharmaceuticals Remicade Biosimilar Product Portfolios and Specifications
Table 74. Synthon Pharmaceuticals Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 75. Synthon Pharmaceuticals Main Business
Table 76. Synthon Pharmaceuticals Latest Developments
Table 77. LG Life Sciences Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 78. LG Life Sciences Remicade Biosimilar Product Portfolios and Specifications
Table 79. LG Life Sciences Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 80. LG Life Sciences Main Business
Table 81. LG Life Sciences Latest Developments
Table 82. Novartis (Sandoz) Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 83. Novartis (Sandoz) Remicade Biosimilar Product Portfolios and Specifications
Table 84. Novartis (Sandoz) Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 85. Novartis (Sandoz) Main Business
Table 86. Novartis (Sandoz) Latest Developments
Table 87. Celltrion Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 88. Celltrion Remicade Biosimilar Product Portfolios and Specifications
Table 89. Celltrion Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 90. Celltrion Main Business
Table 91. Celltrion Latest Developments
Table 92. Biocon Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 93. Biocon Remicade Biosimilar Product Portfolios and Specifications
Table 94. Biocon Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 95. Biocon Main Business
Table 96. Biocon Latest Developments
Table 97. Hospira Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 98. Hospira Remicade Biosimilar Product Portfolios and Specifications
Table 99. Hospira Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 100. Hospira Main Business
Table 101. Hospira Latest Developments
Table 102. Merck Serono (Merck Group) Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 103. Merck Serono (Merck Group) Remicade Biosimilar Product Portfolios and Specifications
Table 104. Merck Serono (Merck Group) Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 105. Merck Serono (Merck Group) Main Business
Table 106. Merck Serono (Merck Group) Latest Developments
Table 107. Biogen idec Inc. Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 108. Biogen idec Inc. Remicade Biosimilar Product Portfolios and Specifications
Table 109. Biogen idec Inc. Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 110. Biogen idec Inc. Main Business
Table 111. Biogen idec Inc. Latest Developments
Table 112. Genentech (Roche Group) Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 113. Genentech (Roche Group) Remicade Biosimilar Product Portfolios and Specifications
Table 114. Genentech (Roche Group) Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 115. Genentech (Roche Group) Main Business
Table 116. Genentech (Roche Group) Latest Developments
Table 117. Fosun Pharmaceutical Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 118. Fosun Pharmaceutical Remicade Biosimilar Product Portfolios and Specifications
Table 119. Fosun Pharmaceutical Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 120. Fosun Pharmaceutical Main Business
Table 121. Fosun Pharmaceutical Latest Developments
Table 122. Livzon Pharmaceutical Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 123. Livzon Pharmaceutical Remicade Biosimilar Product Portfolios and Specifications
Table 124. Livzon Pharmaceutical Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 125. Livzon Pharmaceutical Main Business
Table 126. Livzon Pharmaceutical Latest Developments
Table 127. Anke Biotechnology Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 128. Anke Biotechnology Remicade Biosimilar Product Portfolios and Specifications
Table 129. Anke Biotechnology Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 130. Anke Biotechnology Main Business
Table 131. Anke Biotechnology Latest Developments
Table 132. Hualan Biological Engineering Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 133. Hualan Biological Engineering Remicade Biosimilar Product Portfolios and Specifications
Table 134. Hualan Biological Engineering Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 135. Hualan Biological Engineering Main Business
Table 136. Hualan Biological Engineering Latest Developments
Table 137. Walvax Biotechnology Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 138. Walvax Biotechnology Remicade Biosimilar Product Portfolios and Specifications
Table 139. Walvax Biotechnology Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 140. Walvax Biotechnology Main Business
Table 141. Walvax Biotechnology Latest Developments
Table 142. Hisun Pharmaceutical Basic Information, Remicade Biosimilar Manufacturing Base, Sales Area and Its Competitors
Table 143. Hisun Pharmaceutical Remicade Biosimilar Product Portfolios and Specifications
Table 144. Hisun Pharmaceutical Remicade Biosimilar Sales (L), Revenue ($ Million), Price (US$/Ml) and Gross Margin (2020-2025)
Table 145. Hisun Pharmaceutical Main Business
Table 146. Hisun Pharmaceutical Latest Developments
LIST OF FIGURES
Figure 1. Picture of Remicade Biosimilar
Figure 2. Remicade Biosimilar Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Remicade Biosimilar Sales Growth Rate 2020-2031 (L)
Figure 7. Global Remicade Biosimilar Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Remicade Biosimilar Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Remicade Biosimilar Sales Market Share by Country/Region (2024)
Figure 10. Remicade Biosimilar Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 100mg/10ml
Figure 12. Product Picture of 500mg/50ml
Figure 13. Global Remicade Biosimilar Sales Market Share by Type in 2025
Figure 14. Global Remicade Biosimilar Revenue Market Share by Type (2020-2025)
Figure 15. Remicade Biosimilar Consumed in Blood Disorders
Figure 16. Global Remicade Biosimilar Market: Blood Disorders (2020-2025) & (L)
Figure 17. Remicade Biosimilar Consumed in Oncology Diseases
Figure 18. Global Remicade Biosimilar Market: Oncology Diseases (2020-2025) & (L)
Figure 19. Global Remicade Biosimilar Sale Market Share by Application (2024)
Figure 20. Global Remicade Biosimilar Revenue Market Share by Application in 2025
Figure 21. Remicade Biosimilar Sales by Company in 2025 (L)
Figure 22. Global Remicade Biosimilar Sales Market Share by Company in 2025
Figure 23. Remicade Biosimilar Revenue by Company in 2025 ($ millions)
Figure 24. Global Remicade Biosimilar Revenue Market Share by Company in 2025
Figure 25. Global Remicade Biosimilar Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Remicade Biosimilar Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Remicade Biosimilar Sales 2020-2025 (L)
Figure 28. Americas Remicade Biosimilar Revenue 2020-2025 ($ millions)
Figure 29. APAC Remicade Biosimilar Sales 2020-2025 (L)
Figure 30. APAC Remicade Biosimilar Revenue 2020-2025 ($ millions)
Figure 31. Europe Remicade Biosimilar Sales 2020-2025 (L)
Figure 32. Europe Remicade Biosimilar Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Remicade Biosimilar Sales 2020-2025 (L)
Figure 34. Middle East & Africa Remicade Biosimilar Revenue 2020-2025 ($ millions)
Figure 35. Americas Remicade Biosimilar Sales Market Share by Country in 2025
Figure 36. Americas Remicade Biosimilar Revenue Market Share by Country (2020-2025)
Figure 37. Americas Remicade Biosimilar Sales Market Share by Type (2020-2025)
Figure 38. Americas Remicade Biosimilar Sales Market Share by Application (2020-2025)
Figure 39. United States Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Remicade Biosimilar Sales Market Share by Region in 2025
Figure 44. APAC Remicade Biosimilar Revenue Market Share by Region (2020-2025)
Figure 45. APAC Remicade Biosimilar Sales Market Share by Type (2020-2025)
Figure 46. APAC Remicade Biosimilar Sales Market Share by Application (2020-2025)
Figure 47. China Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 51. India Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Remicade Biosimilar Sales Market Share by Country in 2025
Figure 55. Europe Remicade Biosimilar Revenue Market Share by Country (2020-2025)
Figure 56. Europe Remicade Biosimilar Sales Market Share by Type (2020-2025)
Figure 57. Europe Remicade Biosimilar Sales Market Share by Application (2020-2025)
Figure 58. Germany Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 59. France Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Remicade Biosimilar Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Remicade Biosimilar Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Remicade Biosimilar Sales Market Share by Application (2020-2025)
Figure 66. Egypt Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Remicade Biosimilar in 2025
Figure 72. Manufacturing Process Analysis of Remicade Biosimilar
Figure 73. Industry Chain Structure of Remicade Biosimilar
Figure 74. Channels of Distribution
Figure 75. Global Remicade Biosimilar Sales Market Forecast by Region (2026-2031)
Figure 76. Global Remicade Biosimilar Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Remicade Biosimilar Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Remicade Biosimilar Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Remicade Biosimilar Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Remicade Biosimilar Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Remicade Biosimilar
Figure 2. Remicade Biosimilar Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Remicade Biosimilar Sales Growth Rate 2020-2031 (L)
Figure 7. Global Remicade Biosimilar Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Remicade Biosimilar Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Remicade Biosimilar Sales Market Share by Country/Region (2024)
Figure 10. Remicade Biosimilar Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 100mg/10ml
Figure 12. Product Picture of 500mg/50ml
Figure 13. Global Remicade Biosimilar Sales Market Share by Type in 2025
Figure 14. Global Remicade Biosimilar Revenue Market Share by Type (2020-2025)
Figure 15. Remicade Biosimilar Consumed in Blood Disorders
Figure 16. Global Remicade Biosimilar Market: Blood Disorders (2020-2025) & (L)
Figure 17. Remicade Biosimilar Consumed in Oncology Diseases
Figure 18. Global Remicade Biosimilar Market: Oncology Diseases (2020-2025) & (L)
Figure 19. Global Remicade Biosimilar Sale Market Share by Application (2024)
Figure 20. Global Remicade Biosimilar Revenue Market Share by Application in 2025
Figure 21. Remicade Biosimilar Sales by Company in 2025 (L)
Figure 22. Global Remicade Biosimilar Sales Market Share by Company in 2025
Figure 23. Remicade Biosimilar Revenue by Company in 2025 ($ millions)
Figure 24. Global Remicade Biosimilar Revenue Market Share by Company in 2025
Figure 25. Global Remicade Biosimilar Sales Market Share by Geographic Region (2020-2025)
Figure 26. Global Remicade Biosimilar Revenue Market Share by Geographic Region in 2025
Figure 27. Americas Remicade Biosimilar Sales 2020-2025 (L)
Figure 28. Americas Remicade Biosimilar Revenue 2020-2025 ($ millions)
Figure 29. APAC Remicade Biosimilar Sales 2020-2025 (L)
Figure 30. APAC Remicade Biosimilar Revenue 2020-2025 ($ millions)
Figure 31. Europe Remicade Biosimilar Sales 2020-2025 (L)
Figure 32. Europe Remicade Biosimilar Revenue 2020-2025 ($ millions)
Figure 33. Middle East & Africa Remicade Biosimilar Sales 2020-2025 (L)
Figure 34. Middle East & Africa Remicade Biosimilar Revenue 2020-2025 ($ millions)
Figure 35. Americas Remicade Biosimilar Sales Market Share by Country in 2025
Figure 36. Americas Remicade Biosimilar Revenue Market Share by Country (2020-2025)
Figure 37. Americas Remicade Biosimilar Sales Market Share by Type (2020-2025)
Figure 38. Americas Remicade Biosimilar Sales Market Share by Application (2020-2025)
Figure 39. United States Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 40. Canada Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 41. Mexico Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 42. Brazil Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 43. APAC Remicade Biosimilar Sales Market Share by Region in 2025
Figure 44. APAC Remicade Biosimilar Revenue Market Share by Region (2020-2025)
Figure 45. APAC Remicade Biosimilar Sales Market Share by Type (2020-2025)
Figure 46. APAC Remicade Biosimilar Sales Market Share by Application (2020-2025)
Figure 47. China Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 48. Japan Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 49. South Korea Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 50. Southeast Asia Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 51. India Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 52. Australia Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 53. China Taiwan Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 54. Europe Remicade Biosimilar Sales Market Share by Country in 2025
Figure 55. Europe Remicade Biosimilar Revenue Market Share by Country (2020-2025)
Figure 56. Europe Remicade Biosimilar Sales Market Share by Type (2020-2025)
Figure 57. Europe Remicade Biosimilar Sales Market Share by Application (2020-2025)
Figure 58. Germany Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 59. France Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 60. UK Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 61. Italy Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 62. Russia Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 63. Middle East & Africa Remicade Biosimilar Sales Market Share by Country (2020-2025)
Figure 64. Middle East & Africa Remicade Biosimilar Sales Market Share by Type (2020-2025)
Figure 65. Middle East & Africa Remicade Biosimilar Sales Market Share by Application (2020-2025)
Figure 66. Egypt Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 67. South Africa Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 68. Israel Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 69. Turkey Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 70. GCC Countries Remicade Biosimilar Revenue Growth 2020-2025 ($ millions)
Figure 71. Manufacturing Cost Structure Analysis of Remicade Biosimilar in 2025
Figure 72. Manufacturing Process Analysis of Remicade Biosimilar
Figure 73. Industry Chain Structure of Remicade Biosimilar
Figure 74. Channels of Distribution
Figure 75. Global Remicade Biosimilar Sales Market Forecast by Region (2026-2031)
Figure 76. Global Remicade Biosimilar Revenue Market Share Forecast by Region (2026-2031)
Figure 77. Global Remicade Biosimilar Sales Market Share Forecast by Type (2026-2031)
Figure 78. Global Remicade Biosimilar Revenue Market Share Forecast by Type (2026-2031)
Figure 79. Global Remicade Biosimilar Sales Market Share Forecast by Application (2026-2031)
Figure 80. Global Remicade Biosimilar Revenue Market Share Forecast by Application (2026-2031)
